SANGINITA.NSSANGINITA.NSNSE
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +111.03% | -6.01% | -19.38% | -28.11% | -29.35% |
| Gross Profit Growth | +42.76% | +219.82% | -1.81% | -34.98% | -194.68% |
| EBITDA Growth | -11.35% | +578.04% | -11.39% | -76.31% | -240.91% |
| Operating Income Growth | -33.27% | +0.00% | -74.86% | -128.66% | -437.82% |
| Net Income Growth | -69.07% | +0.00% | -65.69% | -411.49% | -2076.14% |
| EPS Growth | -80.77% | +0.00% | -75.00% | -409.52% | -2240.00% |
| EPS Diluted Growth | -80.77% | +0.00% | -75.00% | -409.52% | -2240.00% |
| Weighted Average Shares Growth | +63.08% | +63.08% | +37.65% | +0.60% | -8.02% |
| Weighted Average Shares Diluted Growth | +63.08% | +63.08% | +37.65% | +0.60% | -8.02% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -100.00% | +38.71% | +0.00% | -15.27% | +0.00% |
| Inventory Growth | -100.00% | -0.70% | +0.00% | +0.70% | +0.00% |
| Asset Growth | -100.00% | +19.06% | +0.00% | -1.00% | +0.00% |
| Book Value per Share Growth | -17.15% | -15.61% | -0.02% | -1.45% | +0.00% |
| Debt Growth | -100.00% | -19.75% | +0.00% | -8.73% | +0.00% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | -100.00% | +6.35% | -100.00% | -63.20% | +0.00% |